Rosaleen McLaughlin

Rosaleen 'Rosie' McLaughlin joined InstaPill as Chief of the Scientific Advisory Board, bringing with her an illustrious career shaped by decades of leadership across premier pharmaceutical innovators, including Catalent, GSK and Serb Pharmaceuticals. A distinguished authority in advanced drug delivery, Rosie is celebrated for her pioneering contribution to the evolution of oral lyophilisate platforms. Her rare blend of scientific rigour and visionary flair has consistently transformed innovation into meaningful commercial impact. At InstaPill, she assumes stewardship of the company's scientific agenda, elegantly guiding strategic direction, nurturing portfolio excellence, and championing the next generation of patient-centric, breakthrough therapies with precision and purpose.